Business - Briefly   

Gland Pharma gets $30 m private funding

HYDERABAD: Gland Pharma, a closely-held company into advanced drug delivery mechanism, has raised $30 million (about Rs. 120 crore) from Evolvence India Life Sciences Fund, a private equity (PE) fund. The investment will be used for expansion and entering into manufacturing of biosimilars, anti-caner drugs and other generics. — Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Infosys Q3 net up 17 p.c. at Rs. 4,271 crore
Apex court allows Reliance Power to go ahead with public offering
Taj Hotels signs pact with Saraya Islands
OMX expertise for BSE
Longer tenure Index options
Bajaj to market Kawasaki bikes
Tata Motors’ Argentina plans
Sensex gains 245 points
ICAR regional panel meets
Training for entrepreneurs
Drop in output
Car dealer flooded with calls
Cusat inks pact for technology transfer
Delphi-TVS to invest Rs. 500 cr.
Exchange Rates
Bullion Rates
Industrial growth dips
SBI invites bids for debit card solutions
Inflation remains unchanged
Rolls-Royce plans to cut 2,300 jobs
Mittal, Sarin named in U.K.’s Power 100 list
Volvo, Azad Group form venture
Axiom Design expands operation
Ranbaxy enters chyawanprash segment
Carlyle group to invest in Repco Home
ICICI Bank launches iMobile
Control Print ties up with German firm
Gland Pharma gets $30 m private funding

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu